Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer-Reference-Cited by-同舟云学术

Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer

Published:2019-06-04 Issue:2 Volume:146 Page:487-495
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Sheng Shuyan¹,Xu Ye¹,Guo Yonghai¹,Yao Lu¹,Hu Li¹,Ouyang Tao¹,Li Jinfeng¹,Wang Tianfeng¹,Fan Zhaoqing¹,Fan Tie¹,Lin Benyao¹,Xie Yuntao¹^ORCID

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast CenterPeking University Cancer Hospital & Institute Beijing People's Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32424

Reference30 articles.

1. Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms

2. A cancer family syndrome in twenty‐four kindreds;Li FP;Cancer Res,1988

3. Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study

4. Germline Mutations in Predisposition Genes in Pediatric Cancer

5. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li‐Fraumeni families;Birch JM;Cancer Res,1994

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Impact of Constitutional Genomic Testing on Current Breast Cancer Care;Clinical Oncology;2024-08

2. Pedigree analysis exploring the inconsistency between diverse phenotypes and testing criteria for germline TP53 mutations in Chinese women with breast cancer;Breast Cancer Research and Treatment;2024-06-15

3. Clinical and genetic characteristics of carriers of the TP53 c.541C > T, p.Arg181Cys pathogenic variant causing hereditary cancer in patients of Arab-Muslim descent;Familial Cancer;2024-05-14

4. TP53-associated early breast cancer: new observations from a large cohort;JNCI: Journal of the National Cancer Institute;2024-04-03

5. Low prevalence of germline TP53 and PALB2 mutations in unselected cohort of breast cancer patients from Brunei Darussalam;F1000Research;2023-11-30